Valuation Formosa Laboratories, Inc.

Stocks

End-of-day quote Taiwan S.E. 2026-09-11			5-day change	1st Jan Change
45.25 ^TWD	-2.58%		-1.63%	-23.69%

08-13	Formosa Laboratories, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-14	Formosa Laboratories, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	5,085	7,275	8,839	12,266	8,274	7,131
Change	-	43.07%	21.49%	38.78%	-32.55%	-13.81%
Enterprise Value (EV) ¹	8,446	9,602	11,008	13,819	9,470	8,247
Change	-	13.69%	14.64%	25.53%	-31.47%	-12.91%
P/E	13.6x	5.86x	21.7x	97.2x	52.9x	16.3x
PBR	0.98x	0.98x	1.18x	1.62x	1.08x	0.92x
PEG	-	0x	-0.3x	-1.4x	2.2x	0x
Capitalization / Revenue	1.65x	2.32x	2.35x	2.81x	1.75x	1.47x
EV / Revenue	2.75x	3.06x	2.92x	3.17x	2x	1.7x
EV / EBITDA	18.1x	32.4x	17.6x	12.3x	7.73x	6.14x
EV / EBIT	302x	-57.2x	67.3x	20.5x	13x	10.3x
EV / FCF	-11.8x	-56.1x	47x	37.1x	-128x	20x
FCF Yield	-8.46%	-1.78%	2.13%	2.69%	-0.78%	4.99%
Dividend per Share ²	-	2	1	2	3	3
Rate of return	-	3.31%	1.36%	1.96%	4.36%	5.06%
EPS ²	3.459	10.32	3.39	1.05	1.3	3.64
Distribution rate	-	19.4%	29.5%	191%	231%	82.4%
Net sales ¹	3,075	3,142	3,766	4,360	4,731	4,851
EBITDA ¹	467.6	296.6	623.8	1,127	1,225	1,344
EBIT ¹	28.01	-168	163.5	675	725.9	803.2
Net income ¹	400	1,249	409.4	126.2	157.3	441.1
Net Debt ¹	3,361	2,327	2,169	1,553	1,196	1,115
Reference price ²	46.95	60.50	73.50	102.00	68.80	59.30
Nbr of stocks (in thousands)	108,313	120,256	120,256	120,256	120,256	120,256
Announcement Date	3/8/21	3/11/22	3/15/23	3/12/24	3/13/25	3/13/26

¹TWD in Million²TWD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
FORMOSA LABORATORIES, INC.	-	-	-	-	176M
ELI LILLY AND COMPANY	31.96x	11.62x	23.56x	0.62%	1,001B
JOHNSON & JOHNSON	29.63x	-	-	2.02%	642B
ABBVIE INC.	32.65x	7.56x	15.72x	2.69%	451B
ROCHE HOLDING AG	18.78x	4.58x	11.35x	2.9%	340B
NOVARTIS AG	19.52x	5.11x	12.66x	3.19%	263B
ASTRAZENECA PLC	20.44x	4.2x	12.01x	2.1%	247B
AMGEN INC.	24.19x	6.38x	11.35x	2.64%	207B
NOVO NORDISK A/S	12.74x	4.63x	9.67x	3.94%	197B
GILEAD SCIENCES, INC.	-43.8x	6.4x	24.98x	2.27%	180B
Average	16.23x	6.31x	15.16x	2.48%	352.65B
Weighted average by Cap.	23.23x	7.75x	17.18x	2.04%